Next Steps for Finding Optimal Role for Adjuvant RCC Therapy
Eric A. Singer, MD, MS, discusses future developments that could improve the utilization of adjuvant therapy for high-risk renal cell carcinoma.
Choosing Which Patients Should Receive Adjuvant Therapy for RCC
Eric A. Singer, MD, MS, discusses which patients he believes would benefit most from adjuvant therapy for high-risk renal cell carcinoma.
Pembrolizumab as Adjuvant Therapy for RCC
Eric A. Singer, MD, discusses recent research evaluating adjuvant therapies for patients with high-risk renal cell carcinoma.